JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 HEALTH AUTONOMY [COURSE]Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomyJOIN THE COMMUNITYJoin my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2EMAIL LIST1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6HIRE ME FOR CONSULTING: Consulting: https://bit.ly/3dmUl2H Created with BiorenderOmega-3 Clinical Trials: https://youtu.be/NScltXkIO44?si=DYhUHP8YWU897qhAOmega-3 Brain Mechanisms: https://youtu.be/7dwsjFAP5rQ?si=_5X0LEH3v7vBPsbB0:00 - Introduction0:48 - DHA and Dementia2:56 - Two Problems4:50 - Alzheimer's Risk6:52 - Long-term? How do I apply this?8:50 - Main Points / Key TakeawaysReference[Study 546] Wei BZ, Li L, Dong CW, Tan CC, Alzheimer’s Disease Neuroimaging Initiative, Xu W. The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr. 2023;117(6):1096-1109. doi:10.1016/j.ajcnut.2023.04.001.Funding/Conflicts: Public funding: This study was supported by grants from the National Natural Science Foundation of China (grant 82001136) and the Tai-Shan Scholar Project; data collection and sharing for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) used in this work were funded by the National Institutes of Health (National Institute on Aging and National Institute of Biomedical Imaging and Bioengineering) and the U.S. Department of Defense (award W81XWH-12-2-0012); Non-profit funding: Additional support for ADNI came from organizations such as the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, with private-sector contributions coordinated through the Foundation for the National Institutes of Health;Industry funding: ADNI also received funding from numerous pharmaceutical, biotech, and imaging companies, including AbbVie, Araclón Biotech, BioClinica, Biogen, Bristol-Myers Squibb, CereSpir, Cogstate, Eisai, Elan Pharmaceuticals, Eli Lilly, EuroImmun, F. Hoffmann-La Roche/Genentech, Fujirebio, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy, Johnson & Johnson Pharmaceutical Research & Development, Lumosity, Lundbeck, Merck, Meso Scale Diagnostics, NeuroRx Research, Neurotrack Technologies, Novartis, Pfizer, Piramal Imaging, Servier, Takeda, and Transition Therapeutics; Conflicts of interest: The authors report no conflicts of interest.CRITIQUES, RULES, AND NOTESBe aware of the following rules before posting comments:- Please do not post summaries of the video in the comments - it damages retention on the video and YouTube is less likely to promote it (these videos cost me a lot of money to produce). Critiques of my work are welcome! Please be aware of the following notes & rules before submitting critique:Be mindful that this content is not all encompassing on the subject at hand and is self-limited for brevity to reach a wider audience. Also, be aware that I receive hundreds of YouTube comments per day, so the only way your critique can be considered is if you follow the steps outlined below. Finally, YouTube auto-deletes links, so I do not see most comments with links attached. RULES:If your comment is rude, you will be banned.If your comment is not about the studies/topics at hand (i.e. extending to other outcomes not discussed) or offers critique with no scientific basis, it is unlikely to receive a response.If you can follow these rules, I will try to address your critique and if there is merit, I will add an AMENDMENT to the content in question and pin it so everyone can see it (thank you!). Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes. #omega3 #dementiaprevention #dementiatreatment